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Abstract
Background: The reemergence of epidemic diphtheria in Belarus in 1990s has provided us with
important information on the biology of the disease and the diversity of the causative agent
Corynebacterium diphtheriae. Molecular investigations were conducted with the aim to analyze the
genetic variability of C diphtheriae during the post-epidemic period.
Methods: The biotype and toxigenicity status of 3513 C. diphtheriae strains isolated from all areas
in Belarus during a declining period of diphtheria morbidity (1996–2005) was undertaken. Of these,
384 strains were isolated from diphtheria cases, 1968 from tonsillitis patients, 426 from contacts
and 735 from healthy carriers. Four hundred and thirty two selected strains were ribotyped.
Results: The C diphtheriae gravis biotype, which was prevalent during 1996–2000, was "replaced"
by the mitis biotype during 2001–2005. The distribution of toxigenic C. diphtheriae strains also
decreased from 47.1% (1996) to 5.8% (2005). Changes in the distribution of the epidemic ribotypes
Sankt-Peterburg and Rossija were also observed. During 2001–2005 the proportion of the Sankt-
Peterburg ribotype decreased from 24.3% to 2.3%, in contrast to the Rossija ribotype, that
increased from 25.1% to 49.1%. The circulation of other toxigenic ribotypes (Otchakov, Lyon,
Bangladesh), which were prevalent during the period of high diphtheria incidence, also decreased.
But at the same time, the proportion of non-toxigenic strains with the Cluj and Rossija ribotypes
dramatically increased and accounted for 49.3% and 30.1%, respectively.
Conclusion: The decrease in morbidity correlated with the dramatic decrease in the isolation of
the gravis biotype and Sankt Peterburg ribotype, and the prevalence of the Rossija ribotype along
with other rare ribotypes associated with non-toxigenic strains (Cluj and Rossija, in particular).
Background
The diphtheria epidemic, which emerged in the 1990's in
the newly independent states (NIS) of the former Soviet
Union, was also reported from Belarus. In Belarus, 794
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which 25 were fatal. As a consequence of mass immuniza-
tion the morbidity stabilized in 1996. In 2005 the mor-
bidity decreased to 0.11 per 100 000 population with a
morbidity index of 0.1/100 000 population in advance of
the WHO target for 2010. However, the diphtheria inci-
dence in Belarus remained higher than in previous dec-
ades. Prediction of the epidemic process and elimination
of diphtheria relies mainly on pathogen circulation anal-
ysis. Microbiological monitoring currently includes mod-
ern molecular biologic and genetic approaches for the
investigatation of C. diphtheriae isolates. A variety of
molecular methods including multilocus enzyme electro-
phoresis, ribotyping, pulsed – field gel electrophoresis,
and RAPD have been described. All these showed not only
broad circulation of different genotypes but also revealed
long-term persistence in regions where manifest severe
forms of infections have not been registered [1,2]. The
genetic population of C. diphtheriae was not constant
throughout the epidemic process as confirmed by molec-
ular-epidemiologic methods. The prevalence of epidemic
strains that belonged to a specific biotype and ribotype
was characteristic for each epidemic cycle [3,4]. Epidemic
C. diphtheriae strains, which were prevalent during the
diphtheria epidemic in Belarus, belonged to the gravis bio-
type and were represented by two ribotypes – Sankt-Peter-
burg and Rossija [5]. The diphtheria epidemics in Russia
and the other NIS countries were also associated with
these ribotypes [6-11]. Strains of the Rossija ribotype were
known to have circulated in some Russian regions five
years before the emergence of the epidemic [12]. The data,
obtained from molecular-biologic methods, has provided
much deeper understanding of the diphtheria epidemic
process. However, precise mechanisms of epidemic C.
diphtheriae strains' appearance and their elimination
remain unclear. The aim of this study was to unveil
changes in the C. diphtheriae population during the
decrease of diphtheria morbidity in Belarus.
Methods
Bacterial strains
As a result of the implementation of microbiologic screen-
ing, a collection of C. diphtheriae strains circulating in
Belarus was made at the Institute for Epidemiology and
Microbiology in Minsk during 1996–2005. The permis-
sion for conducting the study was obtained from the Eth-
ical Committee of the Ministry of Health of Belarus. A
total of 3513 C. diphtheriae strains isolated from all areas
in Belarus during the period of morbidity decrease were
analyzed. Of these, 384 strains were isolated from diph-
theria cases, 1968 – from tonsillitis patients, 426 – from
contacts, and 735 – from healthy carriers.
Biotyping and toxigenicity testing
Biotyping was performed according to the World Health
Organization manual for the laboratory diagnosis of
diphtheria [13]. Toxigenicity was determined by the Elek
immunoprecipitation method [13]. The strains also were
tested for the presence of the diphtheria toxin gene by
PCR amplification (with diphtheria toxin gene-specific
primers) as described in manual [13].
Ribotyping
Total of 432 C. diphtheriae strains was used for ribotyping.
The data for 102 strains was taken from previous study
[5]. DNA was extracted by phenol/chloroform method
and ribotyping of the strains was performed as previously
described [5,14].
To date, 86 distinct ribotypes with the endonuclease BstEII
were chosen for the ribotyping database [15], and each
ribotype pattern is represented by a reference strain pos-
sessing a unique geographical name, producing a stable
and reproducible ribotype pattern. These reference strains
also had common ribotype patterns generated by both
endonucleases BstEII and PvuII.
Pheno- and genotyping characteristics of C. diphtheriae
strains circulated from 1996 till 2000 correlated well with
those from the 2001–2005 period.
Results
C. diphtheriae phenotypic characteristics
Analysis of 2000 C. diphtheriae strains, isolated in 1996–
2000, showed that 60.8% belonged to the gravis biotype,
36.7% – to the mitis biotype and 2.5% – to the belfanti bio-
type (Table 1). Amongst 1513 strains isolated from 2001
to 2005, 54.4%, 39.5% and 6.1% belong to the mitis,
gravis and belfanti biotypes respectively. Thus, the diphthe-
ria morbidity decrease was accompanied by changes of
the main C. diphtheriae biotypes. During, 1996–2000 the
gravis biotype predominated (60.8%) and in 2001–2005
the biotype mitis predominated (54.4%).
C. diphtheriae toxigenicity
Analysis of the toxigenicity of C. diphtheriae by the Elek
test showed that during the period of decreased diphthe-
ria morbidity there was a decline in the circulation of tox-
igenic C. diphtheriae. In 1996, toxigenic strains comprised
47.1% of 486 strains analyzed, in 2005 only 6.8% from
292 examined strains were toxigenic (P < 0.001) (Table
2). A decrease in the proportion of toxigenic strains of the
two biotypes was observed: amongst gravis – from 65.8%
to 17.5%, amongst mitis – from 12.5% to 0% (Table 2). In
1996–2005, 142 belfanti strains of a total of 3513 were
non toxigenic. However, isolates of toxigenic gravis bio-
type were prevalent among toxigenic strains during thePage 2 of 7
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100.0%.
C. diphtheriae strains genetic characteristics
Genotypic characteristics of the C. diphtheriae population
was based upon ribotype analysis of 432 strains, includ-
ing 269 toxigenic and 163 non-toxigenic strains. Amongst
these, 220 were from diphtheria cases, 116 – from tonsil-
litis patients, 45 – from contacts, 51 – from healthy carri-
ers. Twenty ribotypes were identified amongst 259 strains,
isolated during 1996–2000 (Table 3). Approximately
49.4% were attributed to the two ribotypes: Sankt-Peter-
burg (24.3%) and Rossija (25.1%). The remainder
(50.6%) were represented by 18 ribotypes, which
occurred with a frequency range of 0.4 to 16.9. During
2001–2005, the numbers of circulating C. diphtheriae
ribotypes decreased to 12, with the Rossija (49.1%) and
Cluj ribotypes (20.8%) being prevalent. Ten ribotypes
represented the remaining 30.1% strains, which occurred
within a frequency range of 0.6 to 11.0%. Evidence from
our investigations showed that eight ribotypes, which
were prevalent in earlier years, were not identified in the
country during 2001–2005. At the same time the circula-
tion level of the Sankt-Peterburg ribotype, which was the
predominant epidemic genotype, decreased from 24.3%
to 2.3%. This resulted in a comparative increase of the
Rossija epidemic ribotype from 25.1% to 49.1%, (P <
0,001) amongst the C. diphtheriae population.
Analysis of the toxigenicity characteristics amongst the
various C. diphtheriae ribotypes demonstrated that despite
a dramatic decrease in the circulation of toxigenic strains
during the period of declining morbidity, the C. diphthe-
riae ribotypes that predominated were still toxigenic. Dur-
ing 2001–2005, all strains belonging to the Sankt-
Peterburg (4 strains), Otchakov (19 strains), Lyon (3
strain), Bangladesh (1 strain) exhibited toxigenic activity
(Table 4). A decrease in the proportion of toxigenic strains
belonging to the Rossija ribotype (from 93.8% to 74.1%)
Table 1: The circulation of C. diphtheriae biotypes in Belarus 
(1996–2005)
Year Total strains C. diphtheriae biotype
gravis mitis belfanti
no. % no. % no. %
1996 486 316 65.0 168 34.6 2 0.4
1997 410 231 56.3 170 41.5 9 2.2
1998 362 209 57.7 129 35.7 24 6.6
1999 339 220 64.9 115 33.9 4 1.2
2000 403 241 59.8 152 37.7 10 2.5
1996–2000 2000 1217 60.8 734 36.7 49 2.5
2001 408 187 45.8 192 47.1 29 7.1
2002 310 130 41.9 160 51.6 20 6.5
2003 213 66 31.0 131 61.5 16 7.5
2004 290 100 34.5 169 58.3 21 7.2
2005 292 114 39.0 171 58.6 7 2.4
2001–2005 1513 597 39.5 823 54.4 93 6.1
Table 2: The circulation of toxigenic C. diphtheriae in Belarus (1996–2005)
Year C. diphtheriae Total strains
gravis mitis belfanti
total strains tox + total strains tox + total strains tox + no. tox +
no. % no. % no. % no. %
1996 316 208 65.8 168 21 12.5 2 0 0 486 229 47.1
1997 231 137 59.3 170 12 7.0 9 0 0 410 149 36.3
1998 209 71 34.0 129 0 0 24 0 0 362 71 19.6
1999 220 99 45.0 115 5 4.3 4 0 0 339 104 30.7
2000 241 115 47.7 152 5 3.3 10 0 0 403 120 29.8
1996–2000 1217 630 51.8 734 43 5.9 49 0 0 2000 673 33.7
2001 187 54 28.9 192 1 0.5 29 0 0 408 55 13.5
2002 130 25 19.2 160 0 0 20 0 0 310 25 8.1
2003 66 12 18.2 131 4 3.1 16 0 0 213 16 7.5
2004 100 40 40.0 169 16 9.5 21 0 0 290 56 19.3
2005 114 20 17.5 171 0 0 7 0 0 292 20 6.8
2001–2005 597 148 24.8 823 21 2.6 93 0 0 1513 169 11.2Page 3 of 7
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in previous years, was reported. We therefore, conclude
that in 2001–2005 not only "toxigenic" ribotypes which
rarely occurred in the epidemic years were eliminated, but
also the proportion of "toxigenic" ribotypes that were
prevalent during the high incidence peak decreased from
55.6% to 27.0%. However, the strains of these ribotypes
that continued to circulate remained toxigenic.
Distinct features amongst various C. diphtheriae ribotypes
were also observed amongst non-toxigenic strains. In
1996–2000 the proportion of non-toxigenic strains from
259 analyzed, accounted for 34.7%, and increased to
42.2% amongst 173 strains examined during 2001–2005.
Non-toxigenic C. diphtheriae strains isolated in 1996–
2000 were attributed to 11 ribotypes (Table 5). The
Moskva (48.9%) and Cluj (36.7%) ribotypes were preva-
lent within this group. The remainder of non-toxigenic
strains (14.4%) was represented by nine ribotypes and
occurred at a frequency of 4.5 % – 1.1%. In 2001–2005
the numbers of circulating non-toxigenic C. diphtheriae
ribotypes decreased to seven with the Cluj (49.3%) and
Rossija (30.1%) ribotypes predominating. Thus, in 2001–
2005, the rare ribotypes (Ras-el-Ma, Thailand, Prahova,
Dagestan, and Gatchina) were eliminated and other more
rarely encountered ribotypes (Close to Pakistan, Neamt)
emerged. Strains of the Cluj ribotype continued to prevail
within the C. diphtheriae population whilst the proportion
of the Moskva ribotype decreased to 11.0%. A relative
increase of non-toxigenic strains was observed amongst
the Rossija ribotype and as a result were second to the Cluj
ribotype.
Discussion
The morbidity of diphtheria in Belarus decreased as a con-
sequence of mass immunization and was accompanied in
1996 by changes in the circulating population of C. diph-
theriae. The gravis biotype which prevailed in 1996–2000
was 'replaced' with the mitis biotype in 2001–2005. This
phenomenon of biotype replacement was may be due to
colonization resistance by the human population to a sin-
gle biotype whilst remaining susceptible to the others
[16].
Simultaneously, we observed a decrease in the proportion
of toxigenic C. diphtheriae strains from 47.1% (1996) to
6.8% (2005). Toxigenic C. diphtheriae strains offer some
selective advantages as compared to non-toxigenic vari-
ants in the non-immune human population. The diphthe-
ria toxin induces local tissue changes promoting the
colonization and maximum reproduction of bacteria
from a clonal group thus contributing to better transmis-
Table 3: C. diphtheriae ribotype prevalence in Belarus (1996–2005)
International designation Former designation (London) 1996–2000 period 2001–2005 period
Total strains % Total strains %
Sankt-Peterburg D1 63 24.3 4 2.3
Rossija D4 65 25.1 85 49.1
Rossija derivation - - 8 4.6
Otchakov D7 18 6.9 19 11.0
Lyon D6 11 4.2 3 1.7
Bangladesh D36 2 0.8 1 0.6
Erlabrunn D15 2 0.8 - -
Schwarzenberg D13 2 0.8 1 0.6
Moskva 44 16.9 8 4.6
Cluj D10 34 13.1 36 20.8
Minsk D30 1 0.4 - -
Gomel 1 0.4 - -
Ras-el-Ma 2 0.8 - -
Thailand D19 1 0.4 - -
Prahova D17 1 0.4 - -
Dagestan D9 1 0.4 - -
Gatchina D5 1 0.4 - -
Buzau 1 0.4 - -
Close to Nan D63 2 0.8 - -
Close to Pakistan D12/D31 - - 2 1.2
Close to Versailles D44/54/55 1 0.4 - -
Neamt D22 - - 1 0.6
New 1–11 6 2.3 5 2.9
Total 259 100.0 173 100.0Page 4 of 7
(page number not for citation purposes)
BMC Infectious Diseases 2006, 6:129 http://www.biomedcentral.com/1471-2334/6/129sion. These toxigenic strains advantages are not found in
immunized individuals [1]. This appears to be a possible
explanation for the decrease in the circulation of toxigenic
C. diphtheriae strains in a highly immune population.
Ribotyping analysis revealed the elimination of rare
ribotypes (toxigenic as well as non-toxigenic) during the
period of decreased morbidity. Thus, several ribotypes
present 0.8–0.4% during 1996–2000 were completely
eliminated. These include Minsk, Gomel, Ras-el-Ma, Thai-
land, Prahova, Dagestan, Gatchina, Close to Nan, Close to
Versailles ribotypes. As regards gravis biotype strains, in
2001–2005 only the Sankt-Peterburg ribotype population
dramatically decreased from 24.3% to 2.3%, in contrast,
the proportion of the Rossija biotype increased from
25.1% to 49.1%. It is generally believed that surface struc-
tures of C. diphtheriae – which are putative colonization
factors – display intraspecies differences [16]. Presuma-
bly, this could explain the complete disappearance of
Sankt-Peterburg ribotype strains whilst preserving another
epidemic ribotype – Rossjia. There was a significant
increase in the proportion of non-toxigenic strains
amongst the total circulating C. diphtheriae with the prev-
alent ribotypes being Cluj and Rossija (49.1% and 20.8%,
respectively) and correlated with the long-term circulation
of non-toxigenic strains of the ribotypes Rossija and Cluj.
On the other hand, the Rossija ribotype demonstrated a
high level of toxigenic strains during 2000–2005 (36.4%
of total analysed, 63.0% of total toxigenic strains). Inter-
estingly, a high level of toxigenic strains (100%) was also
registered for the Otchakov, Lyon and Bangladesh
ribotypes, although their occurrence during 2001–2005
decreased markedly.
In recent years in Belarus, population immunity has
increased (92.4% of protected individuals), but the con-
tinued circulation of toxigenic C. diphtheriae does not
exclude the emergence of sporadic cases of disease, in cer-
tain risk groups. A WHO meeting in 1993 concluded that
to achieve the elimination of diphtheria, a minimum
immunization coverage rate of 90% in children and 75%
in adult is required. [17]. From the data available to date
it is still unclear whether highly virulent and toxigenic
strains will be eliminated from C. diphtheriae population.
Rappuoli et al. [18] suggested that epidemic strains had
some selective advantage, such as increased virulence or
Table 4: Toxigenic strains amongst C. diphtheriae ribotypes (Belarus, 1996–2005)
Ribotype/BstEII 1996–2000 period 2001–2005 period
International designation Former designation (London) Total strains Toxigenic strains Total strains Toxigenic strains
no. % no. %
Sankt-Peterburg D1 63 62 98.4 4 4 100.0
Rossija D4 65 61 93.8 85 63 74.1
Rossija derivation - - - 8 8 100.0
Otchakov D7 18 18 100.0 19 19 100.0
Lyon D6 11 11 100.0 3 3 100.0
Bangladesh D36 2 2 100.0 1 1 100.0
Erlabrunn D15 2 1 50.0 - - -
Schwarzenberg D13 2 2 100.0 1 - -
Moskva 44 - - 8 - -
Cluj D10 34 1 2.9 36 - -
Minsk D30 1 1 100.0 - - -
Gomel 1 1 100.0 - - -
Ras-el-Ma 2 - - - - -
Thailand D19 1 - - - - -
Prahova D17 1 - - - - -
Dagestan D9 1 - - - - -
Gatchina D5 1 - - - - -
Buzau 1 1 100.0 - - -
Close to Nan D63 2 2 100.0 - - -
Close to Pakistan D12/D31 - - - 2 - -
Close to Versailles D44/54/55 1 - - - - -
Neamt D22 - - - 1 - -
New 1–11 6 6 100.0 5 2 40.0
Total 259 169 65.3 173 100 57.8Page 5 of 7
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microbial factors that distinguish epidemic from endemic
strains have not been identified [19,20]. Intense investiga-
tion of advantage-giving virulence factors is necessary for
epidemic strains – this will allow us to identify conditions
necessary for their elimination. Further monitoring of C.
diphtheriae circulation in Belarus with molecular-genetic
methods as well as determination of molecular-genetic
properties in the pathogen population will be the focus of
future investigations.
Conclusion
Diphtheria morbidity decreased in Belarus, which was
accompanied by significant population changes in the
genetic structure of C. diphtheriae. Certain correlations
between the genetic evolution of C. diphtheriae and toxin-
production have been established.
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